Response to: risk of lung disease with the Pi*SS genotype of alpha-1 antitrypsin: the evidence in context

Other authors

Institut Català de la Salut

[Martín T] Pneumology Department, Hospital Beatriz Ângelo, Loures, Portugal. [Miravitlles M] Servei de Pneumologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain

Vall d'Hebron Barcelona Hospital Campus

Publication date

2025-03-17T09:24:31Z

2025-03-17T09:24:31Z

2024

2025-01-24



Abstract

Lung disease; Alpha-1 antitrypsin


Riesgo de enfermedad pulmonar; Alfa-1 antitripsina


Risc de malaltia pulmonar; Alfa-1 antitripsina

Document Type

Article


Published version

Language

English

Publisher

BMC

Related items

Respiratory Research;26

https://doi.org/10.1186/s12931-024-03065-w

Recommended citation

This citation was generated automatically.

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International

http://creativecommons.org/licenses/by-nc-nd/4.0/

This item appears in the following Collection(s)